4.92

3.53% -0.18

After Hours: 4.92

Minerva Neurosciences Inc (NERV)

Overview News Price History Financials Discussions Forecast Stock Split

Minerva Neurosciences Inc stock is traded at $4.92, with a volume of 239.55K. It is down -3.53% in the last 24 hours and down -0.81% over the past month. Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Previous Close:

$5.10

Open:

$5.07

24h Volume:

239.55K

Relative Volume:

1.07

Market Cap:

$229.22M

Revenue:

Net Income/Loss:

$-293.42M

P/E Ratio:

-0.1836

EPS:

-26.8031

Net Cash Flow:

$-13.51M

1W Performance:

-9.39%

1M Performance:

-0.81%

6M Performance:

+13.89%

1Y Performance:

+198.18%

1-Day Range:

$4.72

$5.10

1-Week Range:

$4.72

$5.84

52-Week Range:

$1.59

$12.46

Minerva Neurosciences Inc Stock (NERV) Company Profile

Name

Minerva Neurosciences Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

617-600-7373

Address

1500 DISTRICT AVENUE, BURLINGTON, MA

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

NERV's Discussions on Twitter

Compare NERV vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NERV Minerva Neurosciences Inc	4.92	258.57M	0	-293.42M	-13.51M	-26.80
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-15-26	Initiated	Citizens	Mkt Outperform
Jun-08-20	Reiterated	H.C. Wainwright	Buy
May-14-20	Initiated	BTIG Research	Buy
Oct-02-19	Reiterated	Chardan Capital Markets	Buy
Sep-25-19	Initiated	Chardan Capital Markets	Buy
Sep-18-19	Initiated	William Blair	Outperform
May-31-19	Initiated	H.C. Wainwright	Buy
Sep-01-17	Initiated	Citigroup	Buy
Mar-06-17	Resumed	Jefferies	Buy
May-12-16	Resumed	Jefferies	Buy

View All

Minerva Neurosciences Inc Stock (NERV) Latest News

Jun 29, 2026

Minerva Neurosciences, Inc.(NasdaqCM:NERV) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026

Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026

Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026

Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Minerva Neurosciences, Inc.(NasdaqCM:NERV) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026

Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026

Minerva Neurosciences, Inc.(NasdaqCM:NERV) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 3000 Index - marketscreener.com

Jun 28, 2026

Price to sales forward of Minerva Neurosciences, Inc – NASDAQ:NERV - TradingView

Jun 28, 2026

Jun 26, 2026